• Explore /
  • Poster
  • / A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.

A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.

Abstract Poster

Authors

null

Yusuke Amanuma

Department of Clinical Trial Promotion, Chiba Cancer Center, Chiba, Japan

Yusuke Amanuma , Takeshi Suzuki , Takeshi Kawakami , Masahiko Aoki , Yoshiyuki Yamamoto , Keitaro Shimozaki , Hironaga Satake , Masanori Nojima , Narikazu Boku , Daisuke Takahari

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 266)

DOI

10.1200/JCO.2024.42.3_suppl.266

Abstract #

266

Poster Bd #

C4

Abstract Disclosures

Similar Posters

First Author: Ryosuke Kumanishi

First Author: Ian Chau

First Author: Sylvie Lorenzen

First Author: Takayuki Ando